Developmental outcomes of 3,4-methylenedioxymethamphetamine (ecstasy)-exposed infants in the UK
Human psychopharmacology July 1, 2015 Lynn T. Singer, Derek G. Moore, Meeyoung O. Min et al. 16 citations
A longitudinal study tracked infants whose mothers used MDMA (ecstasy) during pregnancy to assess developmental effects. The review of findings suggests that prenatal MDMA exposure may be associated with delays in motor development and increased risk of fine motor deficits during infancy. The authors indicate that the observed effects appear to be dose-dependent, with heavier use linked to more pronounced developmental differences. The findings point to potential neurodevelopmental consequences of prenatal MDMA exposure, though the authors note that confounding factors such as other substance use and socioeconomic conditions complicate interpretation.